Aurora Cannabis to Host Q4 & FY24 Investor Call

Ticker: ACB · Form: 6-K · Filed: 2024-06-07T00:00:00.000Z

Sentiment: neutral

Topics: earnings-announcement, investor-call, financial-reporting

Related Tickers: ACB

TL;DR

Aurora Cannabis (ACB) hosting Q4/FY24 earnings call June 7th - expect financial results soon.

AI Summary

Aurora Cannabis Inc. announced on June 7, 2024, that it will host an investor conference call to discuss its fourth quarter and fiscal year 2024 results. The company will also file its financial results for the period ending June 30, 2024. Miguel Martin, CEO, signed the report.

Why It Matters

This filing signals an upcoming earnings release, providing investors with crucial financial performance data for Aurora Cannabis.

Risk Assessment

Risk Level: low — This is a routine announcement of an upcoming earnings call and filing, not a material event with immediate financial implications.

Key Players & Entities

FAQ

When will Aurora Cannabis announce its fourth quarter and fiscal year 2024 results?

Aurora Cannabis will host an investor conference call to discuss its fourth quarter and fiscal year 2024 results, with the filing expected for the period ending June 30, 2024.

What is the filing date of this 6-K report?

This 6-K report was filed on June 7, 2024.

Who is the Chief Executive Officer of Aurora Cannabis?

Miguel Martin is the Chief Executive Officer of Aurora Cannabis.

What form is Aurora Cannabis filing with the SEC?

Aurora Cannabis is filing a Form 6-K, which is a report of a foreign private issuer.

What is the fiscal year end for Aurora Cannabis?

Aurora Cannabis's fiscal year ends on March 31.

From the Filing

0001279569-24-000710.txt : 20240607 0001279569-24-000710.hdr.sgml : 20240607 20240607073210 ACCESSION NUMBER: 0001279569-24-000710 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240607 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241027379 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated June 7, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: June 7, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED JUNE 7, 2024 Exhibit 99.1 Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End Information NASDAQ | TSX: ACB EDMONTON, AB, June 7, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2024 on Thursday, June 20, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter fiscal year 2024 before the opening of markets that same day. Conference Call Details DATE: Thursday, June 20, 2024 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events". About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn. Aurora's common sha

View on Read The Filing